person · Reporting owner
KRAEMER HARRY M JANSEN JR
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | January 12, 2024 | January 16, 2024 |
| Leidos Holdings, Inc.LDOS · Entity 668 | Director | October 07, 2026 | October 09, 2026 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date January 12, 2024 · Filed January 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,351.467 |
Reported balance
After 2024-01-12 transaction · row 1
1 source rowRow 1 · 2024-01-12 · Grant · Acquired 46.076 · Balance 148,351.467 F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security | Direct | 2,758.1977 |
Reported balance
After 2024-01-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-12 · Grant · Acquired 10.4546 · Balance 2,758.1977 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Leidos Holdings, Inc.
Report date October 07, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Key Executive Stock Deferral Plan | 132,108.0146 |
Reported balance
After 2026-10-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 297.2259 · Balance 132,108.0146 F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. |
| Common StockSEC Table I · non-derivative | Direct | 93,281 |
Reported balance
Holding disclosure · report date 2026-10-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 93,281 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan.
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 471,076 |
Ending reported balance
After 2026-05-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 458,997 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 12,079 · Balance 471,076 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VWR Corp
Report date November 21, 2017 · Filed November 22, 2017
Section 16 reporting ended · disclosed 2017-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 1
1 source rowRow 1 · 2017-11-21 · Disposition to issuer · Disposed 7,617 · Balance 0 F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest. |
| Director stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.00 · Expires 2021-10-01 | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-11-21 · Disposition to issuer · Disposed 22,617 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest.
F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2018 Filed May 15, 2018 20:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,213 | $0.00 Strike: $14.89 | $0.00 |
DisclosureSEC source: 0001127602-18-017527 · form4.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,213 shares Expires 2018-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 8,635 | $46.93 | $405,240.55 |
DisclosureSEC source: 0001127602-18-017527 · form4.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,481.972 Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 27,213 | $14.89 | $405,201.57 |
DisclosureSEC source: 0001127602-18-017527 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,116.972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 15, 2018 22:32 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 4,070 | $0.00 Strike: $63.08 | $0.00 |
DisclosureSEC source: 0001225208-18-009380 · doc4.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,070 Underlying: Common Stock · 4,070 shares Expires 2025-05-10 F2 · derivative.exercise_date: The option shall vest and become exercisable in full on or after the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of stockholders of the Company is concluded. Read SEC document |
| May 11, 2018 Filed May 15, 2018 22:32 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,624.5136 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009380 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 106,476.37 F1 · shares: Represents the reporting individual's annual equity award for service on the Board of Directors which is paid in the form of restricted share units and includes 38.5136 unreported additional share units that have been credited as dividend equivalents at $63.08 per restricted share unit on the individual's deferred restricted share units under the Company's Key Executive Stock Deferral Plan. Read SEC document |
| April 13, 2018 Filed Apr 13, 2018 20:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6.494 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014549 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,903.972 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Starting with the 1Q2018 quarterly dividend on restricted stock units, the reporting person's method of reporting restricted stock units and the dividends on restricted stock units has been revised to report such grants and dividends in Table I rather than as previously reported in Table II. Accordingly, the balance includes unvested restricted stock units and accrued dividends previously reported in Table II. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 23:07 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 513.891 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-007273 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 104,851.8564 F1 · shares: Dividend euivalent rights. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 23:03 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,990 | $0.00 Strike: $32.15 | $0.00 |
DisclosureSEC source: 0001225208-18-004990 · doc4.xml · derivative · entry 4 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,990 shares Expires 2018-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Relates to options granted April 1, 2011. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 23:03 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 2,417 | $66.40 | $160,488.80 |
DisclosureSEC source: 0001225208-18-004990 · doc4.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,279 F1 · shares: Transaction involved the surrender of shares to Leidos Holdings, Inc. to pay the exercise price and fees for options exercised. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 23:03 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 4,990 | $32.15 | $160,412.03 |
DisclosureSEC source: 0001225208-18-004990 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4.956 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001873 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,672.419 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:30 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 515.9415 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000463 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 104,337.9654 F1 · shares: Dividend equivalents. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 23:35 UTC | VWR Corp VWR · Entity 171619 | Disposition to issuerDirector stock option (right to buy) · Derivative | 22,617 | $12.25 Strike: $21.00 | $277,058.25 |
DisclosureSEC source: 0000899243-17-027340 · doc4.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 22,617 shares Expires 2021-10-01 F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 23:35 UTC | VWR Corp VWR · Entity 171619 | Disposition to issuerCommon stock | 7,617 | $33.25 | $253,265.25 |
DisclosureSEC source: 0000899243-17-027340 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 21:19 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029959 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,667.463 Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 21:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 564.6347 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015835 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 103,822.0239 F1 · shares: Dividend equivalent rights. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.016 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002362 · form.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,662.016 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 12, 2017 Filed Jul 12, 2017 20:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,213 | $0.00 Strike: $17.18 | $0.00 |
DisclosureSEC source: 0001246360-17-002340 · form.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,213 shares Expires 2017-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person exercised the reported stock options, which would have expired on August 13, 2017, and holds the underlying common stock upon exercise. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 12, 2017 Filed Jul 12, 2017 20:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 27,213 | $17.18 | $467,519.34 |
DisclosureSEC source: 0001246360-17-002340 · form.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person exercised the reported stock options, which would have expired on August 13, 2017, and holds the underlying common stock upon exercise. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 17:41 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 642.3842 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-012056 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 103,257.3892 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 7,300 | $0.00 Strike: $62.73 | $0.00 |
DisclosureSEC source: 0001246360-17-002036 · form.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Underlying: Common Stock · 7,300 shares Expires 2027-05-24 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002036 · form.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,444 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs). Read SEC document |
| May 12, 2017 Filed May 16, 2017 22:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 4,788 | $0.00 Strike: $52.70 | $0.00 |
DisclosureSEC source: 0001225208-17-009941 · doc4.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,788 Underlying: Common Stock · 4,788 shares Expires 2024-05-11 F1 · derivative.exercise_date: The options shall vest and become exercisable in full on or after the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 12, 2017 Filed May 16, 2017 22:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009941 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 102,615.005 Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 20:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 6.495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001619 · form.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,247.848 Underlying: Common Stock · 6.495 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 22:29 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 613.4415 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007177 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 100,717.005 F1 · shares: Dividend equivalent rights. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:14 UTC | VWR Corp VWR · Entity 171619 | GrantCommon stock | 3,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001412232-17-000041 · wf-form4_148849283277309.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,617 F1 · kind: This is a grant of restricted stock units under the VWR Corporation 2014 Equity Incentive Plan. The restricted stock units vest annually over three years, subject to the recipient continuously serving on the issuer's board of directors through each such vesting date. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 21:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 6.214 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000193 · form.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,241.353 Underlying: Common Stock · 6.214 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:35 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 619.6102 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000484 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 100,103.5635 F1 · shares: Dividend equivalent rights. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 20:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 6.033 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-006977 · form.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,235.139 Underlying: Common Stock · 6.033 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 22:57 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 726.9818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040163 · doc4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 99,483.9533 F1 · shares: Dividend equivalent rights. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.